These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37104792)

  • 21. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
    Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
    Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
    Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM
    Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
    Colombo C; Belfiore A; Paielli N; De Cecco L; Canevari S; Laurini E; Fermeglia M; Pricl S; Verderio P; Bottelli S; Fiore M; Stacchiotti S; Palassini E; Gronchi A; Pilotti S; Perrone F
    Mol Oncol; 2017 Nov; 11(11):1495-1507. PubMed ID: 28627792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of
    Mir O; Honoré C; Chamseddine AN; Dômont J; Dumont SN; Cavalcanti A; Faron M; Rimareix F; Haddag-Miliani L; Le Péchoux C; Levy A; Court C; Briand S; Fadel E; Mercier O; Bayle A; Brunet A; Ngo C; Rouleau E; Adam J; Le Cesne A
    Clin Cancer Res; 2020 Dec; 26(23):6277-6283. PubMed ID: 32873570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.
    Shkalim Zemer V; Toledano H; Kornreich L; Freud E; Atar E; Avigad S; Feinberg-Gorenshtein G; Fichman S; Issakov J; Dujovny T; Yaniv I; Ash S
    J Pediatr Surg; 2017 Oct; 52(10):1637-1641. PubMed ID: 28209418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast desmoid tumor management in France: toward a new strategy.
    Duazo-Cassin L; Le Guellec S; Lusque A; Chantalat E; Laé M; Terrier P; Coindre JM; Boulet B; Le Boulc'h M; Gangloff D; Meresse T; Chaput B; Al Ali A; Rimareix F; Bonvalot S; Vaysse C
    Breast Cancer Res Treat; 2019 Jul; 176(2):329-335. PubMed ID: 31016642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
    Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
    Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
    van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
    Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies.
    Bishop AJ; Landry JP; Roland CL; Ratan R; Feig BW; Moon BS; Zarzour MA; Wang WL; Lazar AJ; Lewis VO; Torres KE; Guadagnolo BA
    Cancer; 2020 Jul; 126(14):3265-3273. PubMed ID: 32343846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.
    Goy BW; Lee SP; Eilber F; Dorey F; Eckardt J; Fu YS; Juillard GJ; Selch MT
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):659-65. PubMed ID: 9336146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients.
    Peng PD; Hyder O; Mavros MN; Turley R; Groeschl R; Firoozmand A; Lidsky M; Herman JM; Choti M; Ahuja N; Anders R; Blazer DG; Gamblin TC; Pawlik TM
    Ann Surg Oncol; 2012 Dec; 19(13):4036-42. PubMed ID: 22972507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
    Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
    Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
    Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
    Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-catenin S45F mutation results in apoptotic resistance.
    Braggio D; Zewdu A; Londhe P; Yu P; Lopez G; Batte K; Koller D; Costas Casal de Faria F; Casadei L; Strohecker AM; Lev D; Pollock RE
    Oncogene; 2020 Aug; 39(34):5589-5600. PubMed ID: 32651460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
    Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
    Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for local recurrence of upper extremity desmoid tumors.
    Denwood H; Gonzalez MR; Sodhi A; Werenski J; Clunk M; Newman ET; Lozano-Calderón SA
    J Surg Oncol; 2024 Mar; 129(4):813-819. PubMed ID: 38073165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
    An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
    PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.